C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2006
11/23/2006	US20060264618 Protease inhibitor conjugates and antibodies useful in immunoassay
11/23/2006	US20060264616 Modified vitamin K-dependent polypeptides
11/23/2006	US20060264615 Which induce proliferation of lymphocytes in presence of wild-type p35 polypeptide subunit of human interleukin-12; site directed mutagenesis
11/23/2006	US20060264614 Diagnosis using inexpensive and reliable reagents; stimulate immune response; can be used to determine the susceptibility of a particular individual to a treatment regimen
11/23/2006	US20060264613 Soluble CTLA4 proteins produced by recombinant DNA methods; autoimmune diseases, transplant rejection; inhibits the co-stimulatory pathway in T cell activation
11/23/2006	US20060264612 Optimised protein synthesis
11/23/2006	US20060264611 Pancreatic islet transcription factor and uses thereof
11/23/2006	US20060264610 Protein complexes of the tip60 transcriptional activator protein
11/23/2006	US20060264609 Use of heat shock proteins
11/23/2006	US20060264606 Processes for making acylated insulin
11/23/2006	US20060264605 Polypeptides having anti-HIV activity and compositions comprising same
11/23/2006	US20060264604 Anti-HBs monoclonal antibody
11/23/2006	US20060264603 treating edema with Kallikrein inhibitor; bovine pancreatic trypsin inhibitor mutants; possibly ecallantide
11/23/2006	US20060264392 Modulators of angiogenesis
11/23/2006	US20060264374 Conus californicus neurotoxins
11/23/2006	US20060264373 Modified vitamin K-dependent polypeptides
11/23/2006	US20060264370 Antifungal bifunctional molecules, methods of construction and methods of treating fungal infection therewith
11/23/2006	US20060264364 Acetylated therapeutic procytotoxins
11/23/2006	US20060264361 Novel lysophosphatidic acid receptor
11/23/2006	US20060264360 Anti-inflammatory and wound healing effects of lymphoid thymosin beta-4
11/23/2006	US20060263883 Recombinant herpes viruses for preparing recombinant adeno-associated viruses
11/23/2006	US20060263857 Compositions and methods for immunomodulation in an organism
11/23/2006	US20060263856 Expression technology for proteins containing a hybrid isotype antibody moiety
11/23/2006	US20060263855 Intein-mediated protein purification using in vivo expression of an elastin-like protein
11/23/2006	US20060263854 Immunodiagnostic assays using reducing agents
11/23/2006	US20060263851 Soluble interleukin-20 receptor
11/23/2006	US20060263850 to inhibit cytokine-mediated inflammation; two polypeptide subunits, IL-20RA (formerly ZcytoR7) and IL-20RB (formerly DIRS1); one subunit fused to constant region of light chain of an immunoglobulin; the other fused to constant region of heavy chain; light and heavy chains connected via a disulfide bond
11/23/2006	US20060263849 The analogs are resistant to diaminopeptidase IV degradation and bind zinc; are active over an extended time in vivo
11/23/2006	US20060263848 Cysteine-containing peptides having antioxidant properties
11/23/2006	US20060263846 S. penumoniae antigens
11/23/2006	US20060263828 Arrestin chimera comprising naturally occurring beta-arrestin-2 and naturally occurring ubiquitin moiety, where arrestin chimera has increased affinity for GPCR, and where increased affinity means that arrestin chimera remains associated with and traffics with GPCR into endosomes
11/23/2006	US20060263816 Compounds and methods for labeling oligonucleotides
11/23/2006	US20060263804 Functional influenza virus-like particles (VLPs)
11/23/2006	US20060263803 Stem cell growth factor-like polypeptides
11/23/2006	US20060263787 Immunoglobulin-like variable chain binding polypeptides and methods of use
11/23/2006	US20060263786 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of colon cancer
11/23/2006	US20060263781 Regulation of cell surface proteins
11/23/2006	US20060263775 cDNA molecule of a mammalian ELF3 gene; associated with cancer, including ELF3 mRNA intron retention, a novel ELF3 5' untranslated region, and a novel Alu, Alukwd
11/23/2006	US20060263774 Nucleotide sequences, vectors, transformed host cells, polypeptides, antibodies; monocyte/macrophage mediated disorders
11/23/2006	US20060263770 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
11/23/2006	US20060263765 Peptides and mixtures thereof for use in the detection of severe acute respiratory syndrome-associated coronavirus (sars)
11/23/2006	US20060263391 Process for the preparation of hypoallergenic mosaic antigens
11/23/2006	US20060263390 Modified saccharides, conjugates thereof, and their manufacture
11/23/2006	US20060263387 Vaccination of pigs against disease by administering a first recombinant porcine adenovirus vector stably expressing a heterologous nucleotide sequence encoding the antigenic determinant of the disease, preferably Hog Cholera Virus or Pseudorabies virus
11/23/2006	US20060263386 Vaccines
11/23/2006	US20060263383 Prognostic indicator
11/23/2006	US20060263381 Peptide epitopes common to antigens of the same multigene family
11/23/2006	US20060263378 Nucleic acids and proteins from Streptococcus pneumoniae
11/23/2006	US20060263377 Surface protein of Leptospira
11/23/2006	US20060263371 Prognostic indicator
11/23/2006	US20060263370 Prognostic indicator
11/23/2006	US20060263364 Mammalian chemokines; related reagents
11/23/2006	US20060263348 Apolipoprotein l-i and/or derivated polypeptide for the treatment of and/or the prevention of diseases induced by trypanosoma
11/23/2006	US20060263342 Peptides derived from a protein encoded by a polynucleotide overexpressed in human colon cancer cells; bladder, prostate and breast cancers; antimetastasis agents; diagnosis
11/23/2006	US20060263336 Cell targeting methods and compositions
11/23/2006	US20060263334 Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC1 tumor associated antigen
11/23/2006	DE10344545B9 Genetisch modifiziertes Kapsidprotein des Beak and Feather Disease Virus Genetically modified capsid protein of the Beak and Feather Disease Virus
11/23/2006	DE102005023761A1 An die Lck-SH3 und Hck-SH3 Domäne bindende Peptide At the Lck-SH3 and SH3 domain binding peptides Hck
11/23/2006	DE102005022319A1 Verwendung von Histonen zu therapeutischen Zwecken Use of histones for therapeutic purposes
11/23/2006	DE102005022146A1 Isoliertes Photoprotein AQdecay sowie dessen Verwendung An isolated photo AQdecay and its use
11/23/2006	CA2853335A1 Hivcon: an hiv immunogen and uses thereof
11/23/2006	CA2625583A1 Corn plants and seed enhanced for asparagine and protein
11/23/2006	CA2609814A1 Method for amelioration of disease condition induced by mood disorder
11/23/2006	CA2609150A1 Compositions, methods and kits for real-time nucleic acid analysis in live cells
11/23/2006	CA2609043A1 Use of penicillin-binding proteins or polynucleotides or antibodies thereof for preventing or treating bacterial infections
11/23/2006	CA2608767A1 Nucleic acids and polypeptides that are useful in controlling neuronal regeneration
11/23/2006	CA2608004A1 Isolated aqdecay photoprotein and use thereof
11/23/2006	CA2607291A1 Compositions and methods for modulating immune responses
11/23/2006	CA2597511A1 Hivcon: an hiv immunogen and uses thereof
11/23/2006	CA2591624A1 Pasteurella multocida vaccine
11/22/2006	EP1724354A2 Circular DNA molecule with conditional origin of replication, method for preparing same and use thereof in gene therapy
11/22/2006	EP1724352A2 Specific nucleic acids and polypeptide from pathogenic strains of Neisseria
11/22/2006	EP1724351A2 Human Kallikrein-like genes
11/22/2006	EP1724350A1 Method and compositions for the diagnosis and treatment of cancer
11/22/2006	EP1724349A1 TIE Ligand Homologues
11/22/2006	EP1724347A2 DNA & protein binding miniature proteins
11/22/2006	EP1724342A1 Process for producing erysipelothrix rhusiopathiae surface protective antigen mutant in escherichia coli
11/22/2006	EP1724341A1 Novel taste sensation-modifying peptide nas, dna thereof and use of the same
11/22/2006	EP1724339A1 Gene regulation therapy involving ferritin
11/22/2006	EP1724286A1 Variant CD44 polypeptide, polynucleotides encoding same, antibodies directed there against and method of using same for diagnosing and treating inflammatory diseases
11/22/2006	EP1724285A1 Anti-HBs monoclonal antibodies
11/22/2006	EP1724284A2 GLP-1 fusion proteins
11/22/2006	EP1724283A2 Corticotropin releasing factor receptor 2 agonists
11/22/2006	EP1724282A2 Method for the production of non-immunogenic proteins
11/22/2006	EP1724281A1 Pathogenic infection detection compositions and methods
11/22/2006	EP1723974A1 Collagen gel and process for producing the same
11/22/2006	EP1723970A1 Medicinal composition containing cxcr3 inhibitor
11/22/2006	EP1723967A2 Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases
11/22/2006	EP1723964A1 Use of penicillin-binding proteins or polynucleotides or antibodies thereof for preventing or treating bacterial infections
11/22/2006	EP1723950A2 Method of treating dopaminergic gaba-nergic disorders
11/22/2006	EP1723426A2 Immune diagnostic assay to diagnose and monitor tuberculosis infection
11/22/2006	EP1723425A2 Method and device for detecting feline immunodeficiency virus
11/22/2006	EP1723418A2 Binding agents
11/22/2006	EP1723414A2 Npc1l1 (npc3) and methods of identifying ligands thereof
11/22/2006	EP1723251A2 In vitro test system for predicting patient tolerability of therapeutic agents
11/22/2006	EP1723247A1 Recombinant perforin, expression and uses thereof
11/22/2006	EP1723245A2 Glutamine-rich maize seed protein and promoter
11/22/2006	EP1723244A2 Seeds
11/22/2006	EP1723243A1 Plants having improved yield and method for making the same
11/22/2006	EP1723239A1 Method for generating tethered proteins

1 ... 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 ... 2916